Cover Image
市場調查報告書

OTC消費者保健品產品 (粉末狀)的全球市場:產業分析、規模、佔有率、成長、趨勢、預測

OTC Consumer Health Products (Powder Form) Market - (Indication- Skin Care, Nutritional Supplements, Oral Care, Wound Care Management, and Other; Distribution Channel) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

出版商 Transparency Market Research 商品編碼 552207
出版日期 內容資訊 英文 157 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
OTC消費者保健品產品 (粉末狀)的全球市場:產業分析、規模、佔有率、成長、趨勢、預測 OTC Consumer Health Products (Powder Form) Market - (Indication- Skin Care, Nutritional Supplements, Oral Care, Wound Care Management, and Other; Distribution Channel) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025
出版日期: 2017年08月08日 內容資訊: 英文 157 Pages
簡介

本報告提供全球OTC消費者保健品產品 (粉末狀) 市場調查,市場概要,市場成長的各種影響因素及市場機會分析,各症狀、流通管道、地區、主要國家趨勢與市場規模的變化與預測,競爭環境,以及主要企業的簡介等彙整。

第1章 序章

第2章 前提條件、調查手法

第3章 摘要整理

第4章 市場概要

  • 簡介
  • 概要
  • 市場動態
  • 全球OTC消費者保健品產品 (粉末狀) 分析、預測
  • 市場展望
  • 波特的五力分析
  • 價值鏈分析
  • 法規情形
  • 影響從處方藥 (Rx) 轉換到OTC藥的要素

第5章 全球OTC消費者保健品產品 (粉末狀) 分析、預測:各症狀

  • 簡介、定義
  • 主要調查結果/發展
  • 市場規模預測:各症狀
    • 護膚產品
    • 營養補充品
    • 口腔護理產品
    • 創傷護理管理產品
    • 腸胃藥
    • 其他
  • 市場魅力分析:各症狀

第6章 全球OTC消費者保健品產品 (粉末狀) 分析、預測:各流通管道

  • 簡介、定義
  • 主要調查結果/發展
  • 市場規模預測:各流通管道
    • 醫院藥局
    • 獨立型藥局、零售商店
    • 大賣場、超級市場
    • 線上銷售
    • 其他
  • 市場魅力分析:各形態

第7章 全球OTC消費者保健品產品 (粉末狀) 分析、預測:各地區

  • 簡介、定義
  • 主要調查結果/發展
  • 市場規模預測:各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 南美
    • 中東、非洲
  • 市場魅力分析:各地區

第8章 北美的OTC消費者保健品產品 (粉末狀) 分析、預測

  • 簡介
  • 市場規模預測:各國
  • 市場規模預測:各症狀
    • 護膚產品
    • 營養補充品
    • 口腔護理產品
    • 創傷護理管理產品
    • 腸胃藥
    • 其他
  • 市場規模預測:各流通管道
    • 醫院藥局
    • 獨立型藥局、零售商店
    • 大賣場、超級市場
    • 線上銷售
    • 其他
  • 市場魅力分析
    • 各國
    • 各症狀
    • 各流通管道

第9章 歐洲的OTC消費者保健品產品 (粉末狀) 分析、預測

第10章 亞太地區的OTC消費者保健品產品 (粉末狀) 分析、預測

第11章 南美的OTC消費者保健品產品 (粉末狀) 分析、預測

第12章 中東、非洲的OTC消費者保健品產品 (粉末狀) 分析、預測

第13章 競爭情形

  • 主要企業:競爭矩陣
  • 市場佔有率分析:各企業
  • 企業簡介
    • Pfizer, Inc.
    • GlaxoSmithKline plc
    • Johnson & Johnson
    • Sun Pharmaceuticals Ltd.
    • Piramal Enterprises Ltd.
    • Abbott Laboratories
    • Ipsen
    • Bayer AG
    • Sanofi S.A
    • Glenmark Pharmaceuticals Limited
    • American Health, Inc.

圖表清單

目錄

Title:
OTC Consumer Health Products (Powder Form) Market
(Indication- Skin Care, Nutritional Supplements, Oral Care, Wound Care Management, and Gastrointestinal; Distribution Channel - Hospital Pharmacy, Independent Pharmacies and Retail Stores, Hypermarkets and Supermarkets, and Online Sales) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025.

Global OTC Consumer Health Products (Powder Form) Market: Overview

OTC consumer health products (powder form) include the OTC pharmaceutical products which can be defined as the drugs which can be purchased by the customers without the physician's prescription. In addition, OTC consumer health products include nutritional supplements and sports nutrition products, among others. The market for OTC consumer health products (powder form) has been segmented on the basis of indication and distribution channel. On the basis of indication, the market has been segmented into skin care products, nutritional supplement products, oral care products, wound care management products, gastrointestinal products and others. On the basis of distribution channel, the market has been segmented into hospital pharmacy, independent pharmacies and retail stores, hypermarkets and supermarkets and others.

Global OTC Consumer Health Products (Powder Form) Market: Research Methodology

The research is a combination of primary and secondary research, conducted for understanding and arriving at trends, used to forecast the expected revenue of OTC consumer health products (powder form) instruments and consumables in the near future. Primary research formed the bulk of our research efforts with information collected from in-depth interviews and discussions with a number of key industry experts and opinion leaders. Secondary research involved study of company websites, annual reports, press releases, investor presentations, analyst presentation and various international and national databases. The report provides estimated market size in terms of US$ Mn for each products and end-user. In addition, the report provides estimated market size in terms of US$ Mn for various geographic regions for the period 2015 to 2025, considering the macro and micro environmental factors. The revenue generated from each product was calculated by considering their launch date in the market, customer acceptance, volume sales, price of the product, trends in industry, end user trend, and adoption rate across all the geographies.

The market report comprises an elaborated executive summary, which includes market snapshot that provides information about various segments of the market. It also provides information and data analysis of the market with respect to market segments based on product, end-user, and geography. The market overview section of the report analyzes market dynamics such as drivers, restraints and opportunities that influences the molecular diagnostics market in the current and future scenario.

Market share analysis among the market players is analyzed to signify the contribution of these players in the market in terms of percentage share. All these factors will help the market players to decide about the business strategies and plans to strengthen their positions in the global market. Based on geography, the market has been analyzed for major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Global OTC Consumer Health Products (Powder Form) Market: Competitive Landscape

The report also profiles the major players in the market and provides various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major companies profiled in the OTC consumer health products (powder form) market report are Pfizer, Inc., GlaxosmithKline plc, Johnson & Johnson, Sun Pharmaceuticals Ltd., Piramal Enterprises Ltd., Abbott Laboratories, Ipsen, Bayer AG, Sanofi S.A., Glenmark Pharmaceuticals Limited, and American Health, among others.

The OTC Consumer Health Products (Powder Form) Market has been segmented as follows:

OTC Consumer Health Products (Powder Form) Market, by Indication, Revenue (US$ Mn), 2015-2025

  • Skin Care Products
  • Nutritional Supplements
  • Oral Care Products
  • Wound Care Management Products
  • Gastrointestinal Products
  • Others

OTC Consumer Health Products (Powder Form) Market, by Distribution Channel, Revenue (US$ Mn), 2015-2025

  • Hospital Pharmacy
  • Independent Pharmacies and Retail Stores
  • Hypermarkets and Supermarkets
  • Online Sales
  • Others

OTC Consumer Health Products (Powder Form) Market, by Region, Revenue (US$ Mn) 2015-2025

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • France
    • Germany
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • Japan
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of MEA

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Type Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
    • 4.3.4. Trends
  • 4.4. Global OTC Consumer Health Products (Powder Form) Analysis and Forecasts,2015-2025
  • 4.5. Market Outlook
  • 4.6. Porter's Five Forces Analysis
  • 4.7. Value Chain Analysis
  • 4.8. Regulatory Scenario
  • 4.9. Factors influencing Rx to OTC Switch

5. Global OTC Consumer Health Products (Powder Form) Market Analysis and Forecasts, By Indication

  • 5.1. Introduction & Definition
  • 5.2. Key Findings / Developments
  • 5.3. Market Value Forecast By Indication, 2015-2025
    • 5.3.1. Skin Care products
    • 5.3.2. Nutritional Supplement Products
    • 5.3.3. Oral Care Products
    • 5.3.4. Wound Care Management Products
    • 5.3.5. Gastrointestinal Products
    • 5.3.6. Others
  • 5.4. Market Attractiveness, By Indication

6. Global OTC Consumer Health Products (Powder Form) Market Analysis and Forecasts, By Distribution Channel

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast By Distribution Channel, 2015-2025
    • 6.3.1. Hospital Pharmacy
    • 6.3.2. Independent Pharmacies and Retail Stores
    • 6.3.3. Hypermarkets & Supermarkets
    • 6.3.4. Online Sales
    • 6.3.5. Others
  • 6.4. Market Attractiveness By Distribution Channel

7. Global OTC Consumer Health Products (Powder Form) Market Analysis and Forecasts, By Region

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Size (US$ Mn) Forecast, By Region
    • 7.3.1. North America
    • 7.3.2. Europe
    • 7.3.3. Asia Pacific
    • 7.3.4. Latin America
    • 7.3.5. Middle East & Africa
  • 7.4. Market Attractiveness By Region

8. North America OTC Consumer Health Products (Powder Form) Market Analysis and Forecast

  • 8.1. Introduction
    • 8.1.1. Key Findings
  • 8.2. Market Value Forecast By Country, 2015-2025
    • 8.2.1. U.S.
    • 8.2.2. Canada
  • 8.3. Market Size (US$ Mn) Forecast, By Indication
    • 8.3.1. Skin Care products
    • 8.3.2. Nutritional Supplement Products
    • 8.3.3. Oral Care Products
    • 8.3.4. Wound Care Management Products
    • 8.3.5. Gastrointestinal Products
    • 8.3.6. Others
  • 8.4. Market Size (US$ Mn) Forecast, By Distribution Channel
    • 8.4.1. Hospital Pharmacy
    • 8.4.2. Independent Pharmacies and Retail Stores
    • 8.4.3. Hypermarkets & Supermarkets
    • 8.4.4. Online Sales
    • 8.4.5. Others
  • 8.5. Market Attractiveness Analysis
    • 8.5.1. By Country
    • 8.5.2. By Indication
    • 8.5.3. By Distribution Channel

9. Europe OTC Consumer Health Products (Powder Form) Market Analysis and Forecast

  • 9.1. Introduction
    • 9.1.1. Key Findings
  • 9.2. Market Value Forecast By Country, 2015-2025
    • 9.2.1. U.K.
    • 9.2.2. Germany
    • 9.2.3. France
    • 9.2.4. Italy
    • 9.2.5. Spain
    • 9.2.6. Russia
    • 9.2.7. Rest of Europe
  • 9.3. Market Size (US$ Mn) Forecast, By Indication
    • 9.3.1. Skin Care products
    • 9.3.2. Nutritional Supplement Products
    • 9.3.3. Oral Care Products
    • 9.3.4. Wound Care Management Products
    • 9.3.5. Gastrointestinal Products
    • 9.3.6. Others
    • 9.3.7. Market Size (US$ Mn) Forecast, By Distribution Channel
    • 9.3.8. Hospital Pharmacy
    • 9.3.9. Independent Pharmacies and Retail Stores
    • 9.3.10. Hypermarkets & Supermarkets
    • 9.3.11. Online Sales
    • 9.3.12. Others
  • 9.4. Market Attractiveness Analysis
    • 9.4.1. By Country
    • 9.4.2. By Indication
    • 9.4.3. By Distribution Channel

10. Asia Pacific OTC Consumer Health Products (Powder Form) Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
    • 10.1.2. Key Trends
  • 10.2. Market Value Forecast By Country, 2015-2025
    • 10.2.1. India
    • 10.2.2. China
    • 10.2.3. Japan
    • 10.2.4. Australia & New Zealand
    • 10.2.5. Rest of Asia Pacific
  • 10.3. Market Size (US$ Mn) Forecast, By Indication
    • 10.3.1. Skin Care products
    • 10.3.2. Nutritional Supplement Products
    • 10.3.3. Oral Care Products
    • 10.3.4. Wound Care Management Products
    • 10.3.5. Gastrointestinal Products
    • 10.3.6. Others
  • 10.4. Market Size (US$ Mn) Forecast, By Distribution Channel
    • 10.4.1. Hospital Pharmacy
    • 10.4.2. Independent Pharmacies and Retail Stores
    • 10.4.3. Hypermarkets & Supermarkets
    • 10.4.4. Online Sales
    • 10.4.5. Others
  • 10.5. Market Attractiveness Analysis
    • 10.5.1. By Country
    • 10.5.2. By Indication
    • 10.5.3. By Distribution Channel

11. Latin America OTC Consumer Health Products (Powder Form) Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast By Country, 2015-2025
    • 11.2.1. Brazil
    • 11.2.2. Mexico
    • 11.2.3. Rest of Latin America
  • 11.3. Market Size (US$ Mn) Forecast, By Indication
    • 11.3.1. Skin Care products
    • 11.3.2. Nutritional Supplement Products
    • 11.3.3. Oral Care Products
    • 11.3.4. Wound Care Management Products
    • 11.3.5. Gastrointestinal Products
    • 11.3.6. Others
  • 11.4. Market Size (US$ Mn) Forecast, By Distribution Channel
    • 11.4.1. Hospital Pharmacy
    • 11.4.2. Independent Pharmacies and Retail Stores
    • 11.4.3. Hypermarkets & Supermarkets
    • 11.4.4. Online Sales
    • 11.4.5. Others
  • 11.5. Market Attractiveness Analysis
    • 11.5.1. By Country
    • 11.5.2. By Indication
    • 11.5.3. By Distribution Channel

12. Middle East & Africa OTC Consumer Health Products (Powder Form) Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
    • 12.1.2. Key Trends
  • 12.2. Market Value Forecast By Country, 2015-2025
    • 12.2.1. GCC Countries
    • 12.2.2. South Africa
    • 12.2.3. Rest of Middle East & Africa
  • 12.3. Market Size (US$ Mn) Forecast, By Indication
    • 12.3.1. Skin Care products
    • 12.3.2. Nutritional Supplement Products
    • 12.3.3. Oral Care Products
    • 12.3.4. Wound Care Management Products
    • 12.3.5. Gastrointestinal Products
    • 12.3.6. Others
  • 12.4. Market Size (US$ Mn) Forecast, By Distribution Channel
    • 12.4.1. Hospital Pharmacy
    • 12.4.2. Independent Pharmacies and Retail Stores
    • 12.4.3. Hypermarkets & Supermarkets
    • 12.4.4. Online Sales
    • 12.4.5. Others
  • 12.5. Market Attractiveness Analysis
    • 12.5.1. By Country
    • 12.5.2. By Indication
    • 12.5.3. By Distribution Channel

13. Competition Landscape

  • 13.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 13.2. Market Share Analysis By Company (2016)
  • 13.3. Company Profiles (Details - Overview, Financials, Recent Developments, Strategy)
    • 13.3.1. Pfizer, Inc.
      • 13.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.3.1.2. Business Overview
      • 13.3.1.3. Product Portfolio
      • 13.3.1.4. Financial Overview
      • 13.3.1.5. SWOT Analysis
      • 13.3.1.6. Strategic overview
    • 13.3.2. GlaxoSmithKline plc
      • 13.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.3.2.2. Business Overview
      • 13.3.2.3. Product Portfolio
      • 13.3.2.4. Financial Overview
      • 13.3.2.5. SWOT Analysis
      • 13.3.2.6. Strategic overview
    • 13.3.3. Johnson & Johnson
      • 13.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.3.3.2. Business Overview
      • 13.3.3.3. Product Portfolio
      • 13.3.3.4. Financial Overview
      • 13.3.3.5. SWOT Analysis
      • 13.3.3.6. Strategic overview
    • 13.3.4. Sun Pharmaceuticals Ltd.
      • 13.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.3.4.2. Business Overview
      • 13.3.4.3. Product Portfolio
      • 13.3.4.4. Financial Overview
      • 13.3.4.5. SWOT Analysis
      • 13.3.4.6. Strategic overview
    • 13.3.5. Piramal Enterprises Ltd.
      • 13.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.3.5.2. Business Overview
      • 13.3.5.3. Product Portfolio
      • 13.3.5.4. Financial Overview
      • 13.3.5.5. SWOT Analysis
      • 13.3.5.6. Strategic overview
    • 13.3.6. Abbott Laboratories
      • 13.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.3.6.2. Business Overview
      • 13.3.6.3. Product Portfolio
      • 13.3.6.4. Financial Overview
      • 13.3.6.5. SWOT Analysis
      • 13.3.6.6. Strategic overview
    • 13.3.7. Ipsen
      • 13.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.3.7.2. Business Overview
      • 13.3.7.3. Product Portfolio
      • 13.3.7.4. Financial Overview
      • 13.3.7.5. SWOT Analysis
      • 13.3.7.6. Strategic overview
    • 13.3.8. Bayer AG
      • 13.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.3.8.2. Business Overview
      • 13.3.8.3. Product Portfolio
      • 13.3.8.4. Financial Overview
      • 13.3.8.5. SWOT Analysis
      • 13.3.8.6. Strategic overview
    • 13.3.9. Sanofi S.A
      • 13.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.3.9.2. Business Overview
      • 13.3.9.3. Product Portfolio
      • 13.3.9.4. Financial Overview
      • 13.3.9.5. SWOT Analysis
      • 13.3.9.6. Strategic overview
    • 13.3.10. Glenmark Pharmaceuticals Limited
      • 13.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.3.10.2. Business Overview
      • 13.3.10.3. Product Portfolio
      • 13.3.10.4. Financial Overview
      • 13.3.10.5. SWOT Analysis
      • 13.3.10.6. Strategic overview
    • 13.3.11. American Health, Inc.
      • 13.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.3.11.2. Business Overview
      • 13.3.11.3. Product Portfolio
      • 13.3.11.4. Financial Overview
      • 13.3.11.5. SWOT Analysis
      • 13.3.11.6. Strategic overview

List of Tables

  • Table 01: Global OTC Consumer Health Products (powder form) Market Size (US$ Mn) Forecast, by Indication, 2015-2025
  • Table 02: Global OTC Consumer Health Products (powder form) Market Size (US$ Mn) Forecast, by Distribution Channel, 2015-2025
  • Table 03: Global OTC Consumer Health Products (powder form) Market Size (US$ Mn) Forecast, by Region, 2015-2025
  • Table 04: North America OTC Consumer Health Products (Powder Form) Market Size (US$ Mn) Forecast, by Country, 2015-2025
  • Table 05: North America OTC Consumer Health Products (Powder Form) Market Size (US$ Mn) Forecast, by Indication, 2015-2025
  • Table 06: North America OTC Consumer Health Products (Powder Form) Market Size (US$ Mn) Forecast, by Distribution Channel, 2015-2025
  • Table 07: Europe OTC Consumer Health Products (Powder Form) Market Size (US$ Mn) Forecast, by Country, 2015-2025
  • Table 08: Europe OTC Consumer Health Products (Powder Form) Market Size (US$ Mn) Forecast, by Indication, 2015-2025
  • Table 09: Europe OTC Consumer Health Products (Powder Form) Market Size (US$ Mn) Forecast, by Distribution Channel, 2015-2025
  • Table 10: Asia Pacific OTC Consumer Health Products (Powder Form) Market Size (US$ Mn) Forecast, by Country, 2015-2025
  • Table 11: Asia Pacific OTC Consumer Health Products (Powder Form) Market Size (US$ Mn) Forecast, by Indication, 2015-2025
  • Table 12: Asia Pacific OTC Consumer Health Products (Powder Form) Market Size (US$ Mn) Forecast, by Distribution Channel, 2015-2025
  • Table 13: Latin America OTC Consumer Health Products (Powder Form) Market Size (US$ Mn) Forecast, by Country, 2015-2025
  • Table 14: Latin America OTC Consumer Health Products (Powder Form) Market Size (US$ Mn) Forecast, by Indication,
  • Table 15: Latin America OTC Consumer Health Products (Powder Form) Market Size (US$ Mn) Forecast, by Distribution Channel, 2015-2025
  • Table 16: Middle East & Africa OTC Consumer Health Products (Powder Form) Market Size (US$ Mn) Forecast, by Country, 2015-2025
  • Table 17: Middle East & Africa OTC Consumer Health Products (Powder Form) Market Size (US$ Mn) Forecast, by Indication, 2015-2025
  • Table 18: Middle East & Africa OTC Consumer Health Products (Powder Form) Market Size (US$ Mn) Forecast, by Distribution Channel, 2015-2025

List of Figures

  • Figure 01: Global OTC Consumer Health Products (Powder Form) Market Size (US$ Mn) and Y-o-Y Growth (%), and Forecast, 2017-2025
  • Figure 02: Market Value Share By Indication (2017)
  • Figure 03: Market Value Share By Distribution Channel (2017)
  • Figure 04: Market Value Share By Region (2017)
  • Figure 05: Porter's Five Force Analysis
  • Figure 06: Value Chain Analysis
  • Figure 07: Factors considered for successful Rx to OTC switch
  • Figure 08: OTC Drug approval process - U.S.
  • Figure 09: OTC Drug approval process in Japan
  • Figure 10: Global OTC Consumer Health Products (powder form) Market Value Share Analysis, by Indication, 2016 and 2025
  • Figure 11: Global OTC Consumer Health Products Market Revenue (US$ Mn), and Y-o-Y Growth (%), by Skin Care, 2015-2025
  • Figure 12: Global OTC Consumer Health Products Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Nutritional Supplements, 2015-2025
  • Figure 13: Global OTC Consumer Health Products Market Revenue (US$ Mn), and Y-o-Y Growth (%), by Oral Care, 2015-2025
  • Figure 14: Global OTC Consumer Health Products Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Wound Care Management, 2015-2025
  • Figure 15: Global OTC Consumer Health Products Market Revenue (US$ Mn), and Y-o-Y Growth (%), by Gastrointestinal products, 2015-2025
  • Figure 16: Global OTC Consumer Health Products Market Revenue (US$ Mn), and Y-o-Y Growth (%), by Other products, 2015-2025
  • Figure 17: Global OTC Consumer Health Products (powder form) Market Attractiveness, by Indication
  • Figure 18: Global OTC Consumer Health Products (powder form) Market Value Share Analysis, by Distribution Channel, 2016 and 2025
  • Figure 19: Global OTC Consumer Health Products Market Revenue (US$ Mn), and Y-o-Y Growth (%), by Hospital Pharmacy, 2015-2025
  • Figure 20: Global OTC Consumer Health Products Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Independent Pharmacies & Retail Stores, 2015-2025
  • Figure 21: Global OTC Consumer Health Products Market Revenue (US$ Mn), and Y-o-Y Growth (%), by Hypermarkets & Supermarkets, 2015-2025
  • Figure 22: Global OTC Consumer Health Products Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Online Sales, 2015-2025
  • Figure 23: Global Others Market Revenue (US$ Mn), and Y-o-Y Growth (%), 2015-2025
  • Figure 24: Global OTC Consumer Health Products (powder form) Market Attractiveness, by Distribution Channel
  • Figure 25: Global OTC Consumer Health Products (powder form) Market Revenue, US$ Mn, 2015-2025
  • Figure 26: Global OTC Consumer Health Products (powder form) Market Value Share Analysis, by Region, 2016 and 2025
  • Figure 27: Global OTC Consumer Health Products (powder form) Market Attractiveness, by Region
  • Figure 28: North America OTC Consumer Health Products (Powder Form) Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015-2025
  • Figure 29: North America OTC Consumer Health Products (Powder Form) Market Attractiveness, by Country
  • Figure 30: North America OTC Consumer Health Products (Powder Form) Market Value Share Analysis, by Country, 2016 and 2025
  • Figure 31: North America OTC Consumer Health Products (Powder Form) Market Value Share Analysis, by Indication, 2016 and 2025
  • Figure 32: North America OTC Consumer Health Products (Powder Form) Market Value Share Analysis, by Distribution Channel, 2016 and 2025
  • Figure 33: North America OTC Consumer Health Products (Powder Form) Market Attractiveness, by Indication
  • Figure 34: North America OTC Consumer Health Products (Powder Form) Market Attractiveness, by Distribution Channel
  • Figure 35: Europe OTC Consumer Health Products (Powder Form) Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015-2025
  • Figure 36: Europe OTC Consumer Health Products (Powder Form) Market Attractiveness, by Country
  • Figure 37: Europe OTC Consumer Health Products (Powder Form) Market Value Share Analysis, by Country, 2016 and 2025
  • Figure 38: Europe OTC Consumer Health Products (Powder Form) Market Value Share Analysis, by Indication, 2016 and 2025
  • Figure 39: Europe OTC Consumer Health Products (Powder Form) Market Value Share Analysis, by Distribution Channel, 2016 and 2025
  • Figure 40: Europe OTC Consumer Health Products (Powder Form) Market Attractiveness, by Indication
  • Figure 41: Europe OTC Consumer Health Products (Powder Form) Market Attractiveness, by Distribution Channel
  • Figure 42: Asia Pacific OTC Consumer Health Products (Powder Form) Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015-2025
  • Figure 43: Asia Pacific OTC Consumer Health Products (Powder Form) Market Attractiveness, by Country
  • Figure 44: Asia Pacific OTC Consumer Health Products (Powder Form) Market Value Share Analysis, by Country, 2016 and 2025
  • Figure 45: Asia Pacific OTC Consumer Health Products (Powder Form) Market Value Share Analysis, by Indication, 2016 and 2025
  • Figure 46: Asia Pacific OTC Consumer Health Products (Powder Form) Market Value Share Analysis, by Distribution Channel, 2016 and 2025
  • Figure 47: Asia Pacific OTC Consumer Health Products (Powder Form) Market Attractiveness, by Indication
  • Figure 48: Asia Pacific OTC Consumer Health Products (Powder Form) Market Attractiveness, by Distribution Channel
  • Figure 49: Latin America OTC Consumer Health Products (Powder Form) Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015-2025
  • Figure 50: Latin America OTC Consumer Health Products (Powder Form) Market Attractiveness, by Country
  • Figure 51: Latin America OTC Consumer Health Products (Powder Form) Market Value Share Analysis, by Country, 2016 and 2025
  • Figure 52: Latin America OTC Consumer Health Products (Powder Form) Market Value Share Analysis, by Indication, 2016 and 2025
  • Figure 53: Latin America OTC Consumer Health Products (Powder Form) Market Value Share Analysis, by Distribution Channel,
  • Figure 54: Latin America OTC Consumer Health Products (Powder Form) Market Attractiveness, by Indication
  • Figure 55: Latin America OTC Consumer Health Products (Powder Form) Market Attractiveness, by Distribution Channel
  • Figure 56: Middle East & Africa OTC Consumer Health Products (Powder Form) Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015-2025
  • Figure 57: Middle East & Africa OTC Consumer Health Products (Powder Form) Market Attractiveness, by Country
  • Figure 58: Middle East & Africa OTC Consumer Health Products (Powder Form) Market Value Share Analysis, by Country, 2016 and 2025
  • Figure 59: Middle East & Africa OTC Consumer Health Products (Powder Form) Market Value Share Analysis, by Indication, 2016 and 2025
  • Figure 60: Middle East & Africa OTC Consumer Health Products (Powder Form) Market Value Share Analysis, by Distribution Channel, 2016 and 2025
  • Figure 61: Middle East & Africa OTC Consumer Health Products (Powder Form) Market Attractiveness, by Indication
  • Figure 62: Middle East & Africa OTC Consumer Health Products (Powder Form) Market Attractiveness, by Distribution Channel
  • Figure 63: Global OTC Consumer Health Products (powder form) Market Share Analysis, by Company (2016)
  • Figure 64: Pfizer, Inc., Breakdown of Net Sales (2016), by Region
  • Figure 65: Pfizer, Inc., Revenue (US$ Mn) and Y-o-Y Growth (%), 2014-2016
  • Figure 66: GlaxoSmithKline plc, Breakdown of Net Sales, by Segment, 2016
  • Figure 67: GlaxoSmithKline plc, Revenue (US$ Bn) and Y-o-Y Growth (%), 2014-2016
  • Figure 68: Johnson & Johnson, Breakdown of Net Sales, by Region, 2016
  • Figure 69: Johnson & Johnson, Revenue (US$ Mn) and Y-o-Y Growth (%), 2014-2016
  • Figure 70: Sun Pharmaceuticals Ltd., Breakdown of Net Sales, by Region, 2016
  • Figure 71: Sun Pharmaceuticals Ltd., Revenue (US$ Mn) and Y-o-Y Growth (%), 2014-2016
  • Figure 72: Piramal Enterprises Ltd., Breakdown of Net Sales, by Business Segment, 2016
  • Figure 73: Piramal Enterprises Ltd., Revenue (US$ Mn) and Y-o-Y Growth (%), 2014-2016
  • Figure 74: Abbott Laboratories, Breakdown of Net Sales (%Share), by Region (2016)
  • Figure 75: Abbott Laboratories, Revenue (US$ Mn) and Y-o-Y Growth (%), 2014-2016
  • Figure 76: Ipsen, Breakdown of Net Sales, by Segment, 2016
  • Figure 77: Ipsen, Revenue (US$ Mn) and Y-o-Y Growth (%), 2014-2016
  • Figure 78: Bayer AG, Breakdown of Net Sales (%), by Region (2016)
  • Figure 79: Bayer AG, Revenue (US$ Bn) & Y-o-Y Growth (%), 2014-2016
  • Figure 80: Sanofi S.A, Breakdown of Net Sales, by Region, 2016
  • Figure 81: Sanofi S.A, Revenue (US$ Mn) & Y-o-Y Growth (%), 2014-2016
  • Figure 82: Glenmark Pharmaceuticals Limited, Breakdown of Net Sales, by Region, 2016
  • Figure 83: Glenmark Pharmaceuticals Limited, Revenue (US$ Mn) & Y-o-Y Growth (%), 2014-2016
Back to Top